Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: Characterization of effector and memory CD8+-T-cell populations

Infection and Immunity

Volumn 70, Issue 7, 2002, Pages 3493-3499

  Sedegah, Martha ^a   Brice, Gary T ^a   Rogers, William O ^a   Doolan, Denise L ^a   Charoenvit, Yupin ^a   Jones, Trevor R ^a   Majam, Victoria F ^a   Belmonte, Arnel ^a   Lu, Minh ^a   Belmonte, Maria ^a   Carucci, Daniel J ^a   Hoffman, Stephen L ^a  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLASMID DNA; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; MALARIA; MOUSE; NONHUMAN; PLASMODIUM YOELII; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; DNA, PROTOZOAN; FEMALE; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNIZATION, SECONDARY; IMMUNOLOGIC MEMORY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM YOELII; PROTOZOAN PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; VACCINES, DNA; VACCINIA VIRUS;

EID: 0036083954     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.7.3493-3499.2002     Document Type: Article

References (21)

1. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
2. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection
3. Monoclonal, but not polyclonal antibodies protect against Plasmodium yoeli sporozoites
4. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model
5. The complexity of protective immunity against liver-stage malaria
6. Circumventing genetic restriction of protection against malaria with multi-gene DNA immunization: CD8+ T cell, interferon-gamma, and nitric oxide dependent immunity
7. Protein sorting and secretion during CTL killing
8. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans
9. Attacking the infected hepatocyte
10. Gamma-interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites
11. Use of a vaccinia construct expressing the circumsporozoite protein in the analysis of protective immunity to Plasmodium yoelii
12. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein
13. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of a malaria DNA vaccine
14. Improving protective immunity induced by DNA-based immunization: Priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus
15. Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers
16. Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine
17. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria
18. Genetic control of immunity to Plasmodium yoelii sporozoites
19. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine
20. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites